FD 10 - Fezolinetant: nova droga não hormonal para menopausa
Jun 13, 2023•10 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Neste Flashdirect, iremos debater sobre os estudos SKYLIGHT 1 e 2. Ambos embasaram a aprovação pelo FDA do Fezolinetant para tratamento de sintomas vasomotores moderados e graves nas pacientes com menopausa.
For the best experience, listen in Metacast app for iOS or Android